Related Experiment Videos
NGF promotes amyloid precursor protein secretion via muscarinic receptor activation
Abstract:
Processing of beta-amyloid precursor protein (APP) is coupled to several neurotransmitter receptors, including m1 muscarinic (m1AChR), and is associated with decreased amyloid deposition. Muscarinic agonist-stimulated APP secretion and membrane APP were measured in control and in NGF-differentiated PC12 cells stably transfected with m1AChR. This secretion was markedly enhanced following treatment with 50 ng/ml NGF for 3 days, and was observed using either carbachol or the M1-selective agonist AF102B. The effects of NGF were reflected by larger reductions in membrane-associated APP levels following muscarinic stimulation. These observations imply that M1 muscarinic receptors may act in concert with NGF to boost APP processing, and M1-selective agonists may thus be beneficial for reducing amyloid deposition by NGF-responsive neurons.
Insights
Nerve growth factor (NGF) and m1 muscarinic receptors enhance beta-amyloid precursor protein (APP) processing. M1-selective agonists may reduce amyloid deposition in NGF-responsive neurons.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Beta-amyloid precursor protein (APP) processing is linked to neurotransmitter receptors.
- M1 muscarinic acetylcholine receptors (m1AChR) are implicated in modulating APP metabolism.
- Reduced amyloid deposition is associated with specific APP processing pathways.
Purpose of the Study:
- To investigate the combined effects of nerve growth factor (NGF) and m1 muscarinic receptor activation on APP processing.
- To determine if NGF enhances muscarinic agonist-stimulated APP secretion.
- To evaluate the potential of M1-selective agonists in reducing amyloid deposition.
Main Methods:
- Utilized PC12 cells stably transfected with m1AChR.
- Differentiated cells with NGF (50 ng/ml) for 3 days.
- Measured APP secretion and membrane-associated APP levels following stimulation with carbachol or AF102B (M1-selective agonist).
Main Results:
- NGF treatment significantly enhanced muscarinic agonist-stimulated APP secretion.
- NGF treatment led to greater reductions in membrane-associated APP after muscarinic stimulation.
- Both carbachol and the M1-selective agonist AF102B induced these effects.
Conclusions:
- M1 muscarinic receptors and NGF act synergistically to enhance APP processing.
- M1-selective agonists show potential therapeutic benefits for reducing amyloid deposition.
- Targeting M1 muscarinic receptors could be a strategy for neurodegenerative diseases involving amyloid pathology.